Chronic elevation of plasma fibroblast growth factor 19 in long-term farnesoid X receptor agonist therapy, a happy marriage or cause for oncological concern?
by Schaap, Frank G., Jansen, Peter L. M. and Olde Damink, Steven W. M.
Reference:
F. G. Schaap, P. L. M. Jansen and S. W. M. Olde Damink, "Chronic elevation of plasma fibroblast growth factor 19 in long-term farnesoid X receptor agonist therapy, a happy marriage or cause for oncological concern?", Hepatology, vol. 67, no. 2, 2018, pp. 782–784.
BibTeX Entry:
@article{Schaap:718185,
  author          = {Schaap, Frank G. and Jansen, Peter L. M. and Olde Damink, Steven W. M.},
  title           = {Chronic elevation of plasma fibroblast growth factor 19 in long-term farnesoid X receptor agonist therapy, a happy marriage or cause for oncological concern?},
  journaltitle    = {Hepatology},
  year            = {2018},
  doi             = {10.1002/hep.29511},
  journalsubtitle = {Official journal of the American Association for the Study of Liver Diseases},
  keywords        = {Olde Damink-Selection},
  location        = {New York and others},
  number          = {2},
  pages           = {782--784},
  publisher       = {Wiley Interscience},
  reportid        = {RWTH-2018-221570},
  url             = {https://publications.rwth-aachen.de/record/718185},
  volume          = {67},
}